PTGX position history
The shares of Protagonist Therapeutics (PTGX) that BAMCO Inc (Baron Capital) reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2021 Q4: 26,000 shares, $889K, <0.01% of portfolio, New
- 2022 Q1: not held, Exit
- 2022 Q2: not held
- 2022 Q3: not held
- 2022 Q4: not held
- 2023 Q1: not held
- 2023 Q2: not held
- 2023 Q3: not held
- 2023 Q4: not held
- 2024 Q1: not held
- 2024 Q2: not held
- 2024 Q3: not held
- 2024 Q4: not held
- 2025 Q1: not held
- 2025 Q2: not held
- 2025 Q3: not held
- 2025 Q4: 8,300 shares, $725K, <0.01% of portfolio, New
- 2026 Q1: 15,000 shares, $1.6M, <0.01% of portfolio, Add +80.7%
- 2026 Q2: 16,000 shares, $2M, <0.01% of portfolio, Add +6.7%
- 2026 Q3: 16,000 shares, $2.3M, <0.01% of portfolio
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|